购物车
您的购物车当前为空
SHR-2042 是一种GLP-1受体的选择性激动剂。通过激活GLP-1受体,SHR-2042 增强胰岛素的分泌并抑制胰高血糖素的分泌,从而改善血糖控制。当与 sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC) 结合时,通过形成胶束能够促进单体化,提高口服吸收效率。
SHR-2042 是一种GLP-1受体的选择性激动剂。通过激活GLP-1受体,SHR-2042 增强胰岛素的分泌并抑制胰高血糖素的分泌,从而改善血糖控制。当与 sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC) 结合时,通过形成胶束能够促进单体化,提高口服吸收效率。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | SHR-2042 is a selective agonist of the GLP-1 receptor. By activating the GLP-1 receptor, it enhances insulin secretion and suppresses glucagon secretion, thereby improving blood sugar regulation. When combined with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), it forms micelles that promote monomerization, increasing oral absorption efficiency. |
| 分子式 | C205H314N48O63 |
| Sequence | His-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Glu-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-{εLys(C16 acid)} |
| Sequence Short | H-{Aib}-EGTFTSDVSSYLEEEAAKEFIAWLVRGGPSSGAPPPS-{εK(C16 acid)} |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多